Tuesday, October 2, 2018
11:45 am – 12:15 pm
Recent clinical trials have shown that diabetes reversal can be achieved without the risk, costs or side effects of medication or surgery. Employers recognize that individuals with diabetes have health care costs 2.3 times greater than those without, and a majority of thoses costs are passed along to employers. This session will look at how the Nielsen Company brought 75% of their enrolled diabetic population under the medical threshold for type 2 diabetes. Neilsen's results extended beyond diabetes reversal, with sustained improvements in blood pressure, inflammation, cardiovascular markers, insulin resistance and weight loss. Attendees will learn how Nielsen was able to achieve these revolutionary outcomes, and their effect on employee satisfaction and healthcare spend.